¬Nephros Schedules Third Quarter 2025 Financial Results Conference Call
Rhea-AI Summary
Nephros (Nasdaq: NEPH) will file its third-quarter 2025 financial results on Thursday, November 6, 2025 after market close and will host a conference call the same day at 4:30 PM ET.
Participants can join via domestic dial 1 (844) 808-7106 or international dial 1 (412) 317-5285 and should ask to be joined into the Nephros conference call. An audio archive will be posted on the Nephros Investor Relations page shortly after the call.
A replay is available through November 13, 2025 by calling 1 (877) 344-7529 (U.S.) or 1 (412) 317-0088 (international) and entering replay access code 7475880.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, NEPH gained 2.94%, reflecting a moderate positive market reaction. This price movement added approximately $2M to the company's valuation, bringing the market cap to $56M at that time.
Data tracked by StockTitan Argus on the day of publication.
SOUTH ORANGE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Thursday, November 6, 2025 after market close and will host a conference call that same day at 4:30pm ET.
Participants may dial into the call as follows:
Domestic access: 1 (844) 808-7106
International access: 1 (412) 317-5285
Upon joining, please ask to be joined into the Nephros conference call.
An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page.
Alternatively, a replay of the call may be accessed until November 13th, 2025, at 1 (877) 344-7529 or
1 (412) 317-0088 for international callers and entering replay access code: 7475880
About Nephros
Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Nephros goods serve the needs of customers within medical and commercial markets, offering both proactive and emergency solutions for water management.
For more information about Nephros, please visit us at nephros.com.
Investor Relations Contacts:
Kirin Smith, President
PCG Advisory, Inc.
ksmith@pcgadvisory.com
Robert Banks, CEO
Nephros, Inc.
(201) 343-5202 x110
robert.banks@nephros.com